Procter & Gamble Hygiene and Health Care Ltd logo

Procter & Gamble Hygiene and Health Care Ltd

PGHH NSE

Key Fundamentals

SmallcapPersonal CareConsumer Goods
Market Cap
₹27,590 Cr
Volatility
Moderate
P/E Ratio
34.88
EBITDA
₹1,162 Cr
Return on Equity
86.38%
Debt to Equity
0
Book Value
₹232.12
EPS
₹229.57
52W High
₹14,509
52W Low
₹8,419

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Procter & Gamble Hygiene and Health Care Ltd insights

34 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Tapetide Score

Data-driven rating, 0–100. How it works →

Technical Indicators

Key Insights

Strengths

4
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 89.4%
  • Company has been maintaining a healthy dividend payout of 91.5%

Weaknesses

2
  • Stock is trading at 36.6 times its book value
  • The company has delivered a poor sales growth of 7.40% over past five years.

Growth Rate

Revenue Growth
25.49% ↗
Net Income Growth
35.54% ↗
Cash Flow Change
26.21% ↗
ROE
-0.85% ↘
ROCE
-6.71% ↘
EBITDA Margin (Avg.)
0.94% ↗

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 16h ago
AI opinion · based on fundamentals
Risk medium

Procter & Gamble Hygiene and Health Care Ltd trades at a market cap of ₹27,590 Cr with a PE of 34.9x and an exceptionally high ROE averaging 89% over 3 years, but faces headwinds from declining sales (TTM sales growth of -2%) and a stock price that has fallen 36% over the past year.

Bull Case 7
  • Exceptional return on equity with 3-year average ROE of 89% and last year ROE of 115%, indicating highly efficient capital deployment
  • Virtually debt-free balance sheet, reducing financial risk and interest burden
  • Healthy dividend payout ratio of 91.5% with a current dividend yield of 3.01%, providing consistent income to shareholders
  • Compounded profit growth of 15% over 5 years and 14% over 3 years, demonstrating sustained earnings expansion
  • Backed by global parent Procter & Gamble with strong brand portfolio in hygiene and health care categories in India
  • 10-year compounded sales CAGR of 6% shows long-term revenue resilience despite recent slowdown
  • Company has actively reduced debt, strengthening its balance sheet further for future growth investments
Bear Case 8
  • Stock is trading at 36.6x book value, an extremely elevated valuation that leaves little margin of safety
  • Stock price has declined 36% over 1 year and 18% CAGR decline over 3 years, signaling sustained negative market sentiment
  • TTM sales growth is -2%, indicating revenue contraction in the most recent period
  • 5-year compounded sales growth of only 7.4% reflects structurally low top-line momentum for a consumer goods company
  • TTM profit growth is -5%, showing earnings are now declining after years of expansion
  • PE ratio of 34.9x is elevated relative to the earnings decline, suggesting the stock may not have fully priced in the slowdown
  • 10-year stock CAGR of just 2% indicates the company has delivered negligible long-term capital appreciation to shareholders
  • Limited product portfolio focused on feminine hygiene and health care within India restricts addressable market diversification

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 1d ago
Headwinds 1
  • Q1FY26 profit drops 34% YoY Jul 29

    Net profit fell 34% YoY to ₹126.27 crore in Q1FY26, driven by higher advertising costs and lower revenue.

Neutral 1
  • Record date set for AGM/dividend Aug 7

    P&G Hygiene set September 1, 2026 as record date for its 62nd AGM (September 8) and dividend, with payments due by October 6 if approved. An earlier July 10 announcement had indicated August 26 and September 2 dates, suggesting a minor rescheduling.

TL;DR: P&G Hygiene faces near-term earnings pressure with a sharp 34% YoY profit decline in Q1FY26 due to elevated ad spend and softer revenue. There are no notable bullish catalysts in recent news. The upcoming AGM and dividend provide routine shareholder returns but do not offset the earnings deterioration. The trend is weakening and investors should watch for margin recovery signals in Q2.

Quarterly Results

  Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
853
1,138
1,133
1,002
932
1,135
1,248
992
937
1,150
1,262
941
891
Expenses
638
853
824
745
813
845
877
782
671
865
860
723
721
Operating Profit
215
285
310
257
118
290
371
210
266
285
402
218
170
OPM %
25%
25%
27%
26%
13%
26%
30%
21%
28%
25%
32%
23%
19%
Other Income
10
16
16
14
7
8
10
19
8
10
12
12
9
Interest
3
2
3
22
0
2
7
6
0
4
3
3
0
Depreciation
15
14
14
15
13
12
10
10
9
9
10
10
10
PBT
207
284
309
234
112
285
364
213
265
282
402
218
170
Tax %
27%
26%
26%
34%
28%
26%
26%
27%
27%
26%
25%
30%
26%
Net Profit
151
211
229
154
81
212
269
156
192
210
301
153
126
EPS in Rs
46.59
64.91
70.52
47.56
24.97
65.28
82.74
48.09
59.17
64.65
92.87
47.17
38.9
Figures in ₹ Crores

Profit & Loss

  Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025 9mMar 2026TTM
Sales
2,334
2,275
2,320
2,455
2,947
3,002
3,574
3,901
3,918
4,206
3,374
4,290
4,245
Expenses
1,838
1,667
1,646
1,834
2,329
2,396
2,688
3,069
3,048
3,230
2,503
3,119
3,170
Operating Profit
495
608
675
622
618
606
886
832
869
976
871
1,171
1,075
OPM %
21%
27%
29%
25%
21%
20%
25%
21%
22%
23%
26%
27%
25%
Other Income
64
85
67
18
45
42
38
23
40
47
37
42
44
Interest
6
6
10
5
5
6
6
11
11
27
14
9
10
Depreciation
53
52
60
52
50
48
48
53
58
56
32
37
38
PBT
501
636
672
582
607
594
870
790
839
939
862
1,167
1,072
Tax %
31%
34%
36%
36%
31%
27%
25%
27%
19%
28%
26%
27%
—
Net Profit
346
422
433
375
419
433
652
576
678
675
637
856
791
EPS in Rs
107
130
133
115
129
133
201
177
209
208
196
264
244
Div. Payout %
28%
28%
292%
35%
68%
79%
157%
90%
89%
123%
89%
97%
—
Figures in ₹ Crores

Balance Sheet

  Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Equity Capital
32
32
32
32
32
32
32
32
32
32
32
32
Reserves
1,196
1,619
494
773
877
1,125
682
705
914
742
705
721
Borrowings
0
0
0
0
0
0
3
5
4
3
2
1
Other Liabilities
719
515
634
620
708
671
915
940
1,187
1,081
1,015
1,049
Total Liabilities
1,948
2,166
1,160
1,425
1,617
1,828
1,633
1,683
2,137
1,859
1,755
1,804
Fixed Assets
309
317
286
250
234
206
184
164
170
139
131
163
CWIP
39
35
41
21
15
22
38
44
23
28
41
21
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
1,600
1,814
834
1,154
1,368
1,600
1,411
1,475
1,945
1,692
1,583
1,619
Total Assets
1,948
2,166
1,160
1,425
1,617
1,828
1,633
1,683
2,137
1,859
1,755
1,804
Figures in ₹ Crores

Cash Flow

  Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Operating
426
352
445
415
413
474
863
573
826
470
593
924
Investing
28
221
149
-19
34
75
7
-27
-10
1
-34
11
Financing
-105
-122
-1,559
-106
-314
-190
-1,106
-569
-477
-861
-666
-845
Net Cash Flow
349
452
-964
290
134
358
-236
-23
339
-390
-107
91
Free Cash Flow
348
300
401
377
410
423
832
523
781
427
539
893
CFO/OP
127
91
103
111
105
102
126
99
121
79
96
105
Figures in ₹ Crores

Ratios

  Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Debtor Days
18
24
21
22
22
20
15
18
20
21
33
21
Inventory Days
47
53
71
48
60
68
78
55
48
51
64
51
Days Payable
148
134
145
156
162
175
237
183
213
193
235
197
Cash Conversion Cycle
-83
-57
-53
-87
-79
-87
-144
-110
-145
-121
-138
-126
Working Capital Days
4
8
-15
-23
-12
-21
-39
-34
-53
-32
-31
-31
ROCE %
46%
45%
64%
89%
73%
58%
94%
110%
101%
112%
104%
157%

Shareholding Pattern

As of Jun 2026
Promoters 70.64%
DIIs 15.59%
Public 10.04%
Others 2.76%
FIIs 0.98%
Total 100.01%
  Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
70.64%
FIIs
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
1.30%
1.48%
1.57%
1.56%
1.48%
1.43%
1.33%
1.38%
1.11%
1.07%
0.97%
0.98%
DIIs
13.30%
13.30%
13.20%
13.19%
13.60%
13.91%
14.37%
15.28%
15.33%
15.43%
15.44%
15.29%
15.11%
15.16%
15.28%
15.37%
15.51%
15.49%
16.06%
16.04%
15.97%
15.59%
Government
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Public
10.63%
10.58%
10.57%
10.52%
10.43%
10.37%
10.34%
10.22%
10.15%
10.04%
9.90%
9.88%
9.92%
9.87%
9.80%
9.76%
9.76%
9.74%
9.65%
9.69%
9.80%
10.04%
Others
5.43%
5.48%
5.59%
5.65%
5.32%
5.08%
4.65%
3.87%
3.89%
3.89%
2.72%
2.71%
2.76%
2.77%
2.80%
2.80%
2.76%
2.75%
2.54%
2.57%
2.63%
2.76%
No. of Shareholders
39,337
39,806
41,120
40,908
40,819
41,533
43,445
40,495
39,968
39,388
37,069
38,807
39,999
40,671
42,348
42,941
44,877
47,891
49,997
50,969
53,416
57,957

Documents

Frequently Asked Questions about Procter & Gamble Hygiene and Health Care Ltd

What does Procter & Gamble Hygiene and Health Care Ltd do?
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care bran...
Where is Procter & Gamble Hygiene and Health Care Ltd (PGHH) listed?
Procter & Gamble Hygiene and Health Care Ltd is listed on the Indian stock exchanges. It is listed on NSE: PGHH and BSE: 500459. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Procter & Gamble Hygiene and Health Care Ltd belong to?
Procter & Gamble Hygiene and Health Care Ltd operates in the Consumer Goods sector within the Personal Care industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd has a market capitalisation of approximately ₹27590.00 Cr. Based on this, it is classified as a Large Cap stock.
What is the PE ratio of Procter & Gamble Hygiene and Health Care Ltd?
The Price-to-Earnings (PE) ratio of Procter & Gamble Hygiene and Health Care Ltd is 34.88. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Procter & Gamble Hygiene and Health Care Ltd?
Over the past 52 weeks, Procter & Gamble Hygiene and Health Care Ltd has traded between a low of ₹8,419 and a high of ₹14,509. This range helps investors understand the stock's price volatility and recent trading levels.
Does Procter & Gamble Hygiene and Health Care Ltd pay dividends?
Yes, Procter & Gamble Hygiene and Health Care Ltd has a dividend yield of 3.01%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd has a Return on Equity (ROE) of 86.38%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Procter & Gamble Hygiene and Health Care Ltd on Tapetide?
On Tapetide, you can view Procter & Gamble Hygiene and Health Care Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.

Company Information

Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.

Website pg.com/en_IN
Listed 2004-07-07
Face Value ₹ 10
Issued Size 3,24,60,736

Explore More

More in Consumer Goods → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List